Table 2 Baseline characteristics of the study population

Age (years)

55.64 (11.35)

56.50 (6.01)

ns

Sex Male n (%)

14 (100)

14 (100)

ns

 Hypertension n (%)

11 (78.57)

9 (64.28)

ns

 Hyperlipidaemia n (%)

5 (35.71)

7 (50)

ns

 Diabetes n (%)

1 (7.14)

6 (42.85)

0.029*

 Overweight n (%)

8 (57.14)

5 (35.71)

ns

 Obese n (%)

6 (42.85)

6 (42.85)

ns

 BMI (kg/m²)

29.29 (3.62)

28.64 (3.65)

ns

 Waist-hip ratio (cm)

106.42 (8.84)

104.14 (10.21)

ns

 Current smokers n (%)

2 (14.28)

2 (14.28)

ns

 Monovessel n (%)

3 (21.42)

8 (57.14)

ns

 Double vessel n (%)

5 (35.71)

4 (28.57)

ns

 Triple vessel n (%)

5 (35.71)

1 (7.14)

ns

 CABG n (%)

2 (14.3)

1 (7.1)

ns

 PCI n (%)

11 (78.6)

11 (78.6)

ns

 PCI & CABG n (%)

1 (7.1)

2 (14.3)

ns

Systolic blood pressure (mmHg)

115.35 (23.73)

119.35 (24.05)

ns

Diastolic blood pressure (mmHg)

69.28 (11.41)

71.50 (9.48)

ns

 Exercise time (min)

5.47 (2.08)

5.84 (2.66)

ns

 METS

7.10 (1.97)

7.55 (2.77)

ns

 Heart rate maximal (bpm)

132.84 (16.11)

106.21 (32.58)

0.02*

 % of predicted peak HR.

79.86 (12.27)

65.10 (20.09)

0.02*

 Hypertension response n (%)

5 (41.7)

4 (28.6)

ns

 Clinical positive response n (%)

1 (7.1)

0 (0)

ns

 Electrical positive response n (%)

2 (14.3)

0 (0)

ns

 Ejection Fraction (EF)

52.33 (3.51)

51.00 (7.9)

ns

 Total cholesterol (mg/dL)

130.50 (32.16)

145.71 (29.35)

ns

 HDL cholesterol (mg/dL)

37.85 (8.07)

39.84 (9.21)

ns

 LDL cholesterol (mg/dL)

67.17 (23.19)

73.68 (25.62)

ns

 Triglycerides (mg/dL)

161.21 (72.31)

148.35 (58.16)

ns

 Glucose (mg/dL)

94.92 (13.56)

111.00 (28.03)

ns

 HbA1c

5.62 (1.05)

5.72 (0.93)

ns

 SF-36 (score)

53.33 (19.80)

48.44 (20.89)

ns